Addus HomeCare Corporation (NASDAQ:ADUS) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday. The brokerage presently has a $39.00 price objective on the stock. Zacks Investment Research‘s price objective would indicate a potential upside of 12.39% from the stock’s current price.

According to Zacks, “ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company’s services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. “

A number of other equities analysts also recently commented on the company. BidaskClub downgraded Addus HomeCare Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. ValuEngine upgraded Addus HomeCare Corporation from a “hold” rating to a “buy” rating in a report on Tuesday, August 1st. One investment analyst has rated the stock with a sell rating and three have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $34.50.

Addus HomeCare Corporation (NASDAQ:ADUS) traded up 1.01% during mid-day trading on Thursday, reaching $35.05. 47,394 shares of the company traded hands. Addus HomeCare Corporation has a 12-month low of $18.57 and a 12-month high of $40.75. The company’s 50-day moving average is $36.44 and its 200-day moving average is $35.25. The stock has a market capitalization of $402.02 million, a price-to-earnings ratio of 25.02 and a beta of 0.23.

Addus HomeCare Corporation (NASDAQ:ADUS) last announced its earnings results on Monday, August 7th. The company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.01. The company had revenue of $103.60 million during the quarter, compared to the consensus estimate of $104.39 million. Addus HomeCare Corporation had a return on equity of 10.47% and a net margin of 3.94%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.31 earnings per share. Equities analysts predict that Addus HomeCare Corporation will post $1.60 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece was posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2017/08/17/addus-homecare-corporation-adus-stock-rating-upgraded-by-zacks-investment-research.html.

In other Addus HomeCare Corporation news, insider Brenda A. Belger sold 689 shares of the stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $38.15, for a total value of $26,285.35. Following the completion of the transaction, the insider now owns 12,086 shares in the company, valued at $461,080.90. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Brenda A. Belger sold 6,250 shares of the stock in a transaction on Friday, June 9th. The stock was sold at an average price of $38.58, for a total value of $241,125.00. Following the completion of the transaction, the insider now owns 17,331 shares of the company’s stock, valued at approximately $668,629.98. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,939 shares of company stock valued at $456,310. 35.80% of the stock is owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of ADUS. Russell Investments Group Ltd. purchased a new position in Addus HomeCare Corporation during the fourth quarter worth about $130,000. American International Group Inc. increased its position in Addus HomeCare Corporation by 7.0% in the first quarter. American International Group Inc. now owns 4,548 shares of the company’s stock worth $146,000 after buying an additional 299 shares during the period. Hillsdale Investment Management Inc. purchased a new position in Addus HomeCare Corporation during the first quarter worth about $160,000. US Bancorp DE increased its position in Addus HomeCare Corporation by 2.0% in the third quarter. US Bancorp DE now owns 6,218 shares of the company’s stock worth $163,000 after buying an additional 119 shares during the period. Finally, Ellington Management Group LLC purchased a new position in Addus HomeCare Corporation during the fourth quarter worth about $200,000. Institutional investors and hedge funds own 94.17% of the company’s stock.

About Addus HomeCare Corporation

Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company’s personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living.

Get a free copy of the Zacks research report on Addus HomeCare Corporation (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus HomeCare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.